Event Calendar

Sunday. 11 October, 2020 - Saturday. 17 October, 2020
WEEK 42
Tuesday. 13 October, 2020
6:00 pm

Architectural, Engineering, & Construction (Virtual) Forum - 201013

Webinar

"How the Covid-19 Pandemic is Affecting A/E/C Project Management"
presented by David Burstein, P.E., Project Management Consultant/Instructor, PSMJ Resources, Inc.

The PMI Atlanta AEC Forum is a focus group that hosts regular events with ranging topics in the architectural, engineering, and construction fields. We will show the importance of solid project management in these related fields of study.

Presentation DetailsBurtstein-David

For the past 10 years, a growing number of A/E/C firms have been allowing their employees to work from home. But when the Covid-19 pandemic hit, working from home quickly became the norm for most A/E/C firms – whether they were ready or not.

In March of this year, PSMJ Resources conducted an in-depth study of the impact of working from home on both employees and project managers in A/E/C firms. The study was redone in August with the same firms to see what has changed after several months of working from home.

This presentation provides you with the results of this research and discusses how it is affecting project managers in A/E/C firms. Along with some best project management practices from firms that have successfully made the transition from teams that are all together to teams that are working remotely.

Due to coronavirus concerns, we will be hosting this event through webinar. Because of this change, member rate is now $8 and non-member rate is $10.  

Thursday. 15 October, 2020
6:00 pm

Clinical Research (Virtual) Forum - 201015

Webinar

"Bringing COVID-19 Surveillance Products to Market: The Case of nanoMedicina SARS-COV-2 Antigen and Antibody Rapid Diagnostic Tests Under FDA EUA Review"
presented by Dr David Noye, DIT, NanoResearch, Inc / Founder / Chairman

The Clinical Research Forum provides value to the PMI Atlanta community by regularly discussing the various aspects of clinical trial projects with special focus on the need to anticipate, understand, and implement detailed project management activities in a proactive manner for clinical trials in the pharmaceutical industry.

Presentation Details Noye-David

This topic will cover the use of nanotechnology as a pathway for producing diagnostic tests for identifying antigens and antibodies for the detection of the COVID-19 virus. This is currently under review by the FDA.

Summary:
1. Introduction- NanoResearch Inc as an invention and innovation company
2. Differences in design and technological innovations of nanoMedicina SARS-COV-2 Antigen and Antibody Rapid Diagnostic Testing Devices
3. Status of FDA EUA approval process of nanoMedicina SARS-COV-2 Antigen and Antibody Rapid Diagnostic Tests
4. Business model
5. Funding Strategy
6. Conclusions and Recommendations

Due to coronavirus concerns, we will be hosting this event through webinar. Because of this change, member rate is now $8 and non-member rate is $10.